Detailed price information for Monolithic Power Sys (MPWR-Q) from The Globe and Mail including charting and trades.
When payers end a plan, they either want to lose those customers altogether or get those customers to switch to a different, typically pared down and more profitable plan, Brooks Conway, a principal at Oliver Wyman actuarial consulting, told Healthcare Brew.
Clover Health Investments has seen its stock price move sharply in recent years, which puts fresh focus on whether today's valuation lines up with the revenue the business is generating. For anyone following Clover Health, the live question is how that share price ties back to its sales base rather than just to headlines and momentum. Over the past 3 years the stock has returned about 365.0%, which puts real weight on the issue of how much sales investors are effectively paying for at the...
Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
Humana surges after CMS 2027 Medicare Advantage Star Ratings upgrade restores bonus eligibility. Other MA providers didn't fare as well. Read more here.
The Trump administration plans a one-time $90 payment to Medicare enrollees to help them cover Part B premiums. Read more here.
UnitedHealth (UNH), Humana (HUM) and rivals scale back Medicare Advantage plans for 2027 while Alignment Healthcare (ALHC) expands. Read more here.
Clover’s portfolio combines high-choice PPO access and meaningful member benefits with a Clover Assistant-powered care modelWILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its 2027 Medicare Advantage (MA) plan offerings, with a continued focus on PPO choice, affordable
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief Financial Officer Clay Thornton said at Jefferies’ Healthcare Services and Technology Conference in
Conrad Wai, CEO, Counterpart Health, on September 15, 2026, sold 300,000 shares in Clover Health Inv
This is the newest page. Registered accounts read further back.